ID

37831

Descripción

Male Breast Cancer: Understanding the Biology for Improved Patient Care; ODM derived from: https://clinicaltrials.gov/show/NCT01101425

Link

https://clinicaltrials.gov/show/NCT01101425

Palabras clave

Versiones (1)
  1. 26/8/19 26/8/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

26 de agosto de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT01101425

Inglés

Eligibility Breast Cancer NCT01101425

1 formularios  
Criteria
Descripción

Criteria

men with histologically proven invasive breast carcinoma diagnosed since 1990 to 2010.
Descripción

Gender | Invasive carcinoma of breast Disease length

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2,1]
C0853879
UMLS CUI [2,2]
C0872146
a ffpe tissue sample from the primary tumor (e.g. biopsy or surgery) is mandatory
Descripción

Formalin-fixed paraffin-embedded tissue specimen Primary tumor Required | Biopsy | Operative Surgical Procedures

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2711483
UMLS CUI [1,2]
C0677930
UMLS CUI [1,3]
C1514873
UMLS CUI [2]
C0005558
UMLS CUI [3]
C0543467
prospective part:
Descripción

Part prospective

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0449719
UMLS CUI [1,2]
C0023981
all men, with histologically proven invasive breast cancer, newly presenting at the center irrespective of the stage of disease, initial diagnosis date or treatment received.
Descripción

Gender | Invasive carcinoma of breast | Study Subject Participation Status newly present | Independent of Disease stage | Date of diagnosis Initial | Treatment Initial

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0853879
UMLS CUI [3,1]
C2348568
UMLS CUI [3,2]
C0750546
UMLS CUI [3,3]
C0150312
UMLS CUI [4,1]
C0332291
UMLS CUI [4,2]
C0699749
UMLS CUI [5,1]
C2316983
UMLS CUI [5,2]
C0205265
UMLS CUI [6,1]
C0087111
UMLS CUI [6,2]
C0205265
patients cannot be registered in both the retrospective and protective parts of the study
Descripción

Study Subject Participation Status | Retrospective Study | Protection Study

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0035363
UMLS CUI [3,1]
C1545588
UMLS CUI [3,2]
C0947630
patients who newly present at the center in the 3 months prior to center activation are still eligible as long as they were not previously included in the retrospective part of the study
Descripción

Study Subject Participation Status newly present | Participation Retrospective Study Excluded

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C0750546
UMLS CUI [1,3]
C0150312
UMLS CUI [2,1]
C0679823
UMLS CUI [2,2]
C0035363
UMLS CUI [2,3]
C0332196
before patient registration, written informed consent must be obtained according to ich/gcp, and national/local regulations.
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
collection of left-over ffpe and frozen tumor samples as well as blood is optional.
Descripción

Formalin-fixed paraffin-embedded tissue specimen Residual Optional | Tumor tissue sample Frozen Optional | Blood specimen Optional

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2711483
UMLS CUI [1,2]
C1609982
UMLS CUI [1,3]
C1518600
UMLS CUI [2,1]
C0475358
UMLS CUI [2,2]
C0016701
UMLS CUI [2,3]
C1518600
UMLS CUI [3,1]
C0178913
UMLS CUI [3,2]
C1518600
both parts:
Descripción

Parts Both

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0449719
UMLS CUI [1,2]
C1706086
concomitant dcis or lcis are allowed only if invasive cancer is present.
Descripción

Noninfiltrating Intraductal Carcinoma allowed | Condition Invasive cancer Present | Lobular carcinoma in situ of breast allowed

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0007124
UMLS CUI [1,2]
C0683607
UMLS CUI [2,1]
C1705253
UMLS CUI [2,2]
C0677898
UMLS CUI [2,3]
C0150312
UMLS CUI [3,1]
C0279563
UMLS CUI [3,2]
C0683607
patients should be 18 years or over at the time of diagnosis.
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
the study will accept all stages of disease (e.g. early bc, locally advanced and metastatic disease) independent of the treatment received. patients with past or concurrent other malignancies are eligible.
Descripción

Disease stage All Acceptable | Early-Stage Breast Carcinoma | Locally advanced breast cancer | Neoplasm Metastasis | Independent of Treatment | Cancer Other Eligible

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0699749
UMLS CUI [1,2]
C0444868
UMLS CUI [1,3]
C1879533
UMLS CUI [2]
C2986665
UMLS CUI [3]
C3495949
UMLS CUI [4]
C0027627
UMLS CUI [5,1]
C0332291
UMLS CUI [5,2]
C0087111
UMLS CUI [6,1]
C1707251
UMLS CUI [6,2]
C1548635
Volver a la parte superior de la página

Similar models

Eligibility Breast Cancer NCT01101425

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Gender | Invasive carcinoma of breast Disease length
Item
men with histologically proven invasive breast carcinoma diagnosed since 1990 to 2010.
boolean
C0079399 (UMLS CUI [1])
C0853879 (UMLS CUI [2,1])
C0872146 (UMLS CUI [2,2])
Formalin-fixed paraffin-embedded tissue specimen Primary tumor Required | Biopsy | Operative Surgical Procedures
Item
a ffpe tissue sample from the primary tumor (e.g. biopsy or surgery) is mandatory
boolean
C2711483 (UMLS CUI [1,1])
C0677930 (UMLS CUI [1,2])
C1514873 (UMLS CUI [1,3])
C0005558 (UMLS CUI [2])
C0543467 (UMLS CUI [3])
Part prospective
Item
prospective part:
boolean
C0449719 (UMLS CUI [1,1])
C0023981 (UMLS CUI [1,2])
Gender | Invasive carcinoma of breast | Study Subject Participation Status newly present | Independent of Disease stage | Date of diagnosis Initial | Treatment Initial
Item
all men, with histologically proven invasive breast cancer, newly presenting at the center irrespective of the stage of disease, initial diagnosis date or treatment received.
boolean
C0079399 (UMLS CUI [1])
C0853879 (UMLS CUI [2])
C2348568 (UMLS CUI [3,1])
C0750546 (UMLS CUI [3,2])
C0150312 (UMLS CUI [3,3])
C0332291 (UMLS CUI [4,1])
C0699749 (UMLS CUI [4,2])
C2316983 (UMLS CUI [5,1])
C0205265 (UMLS CUI [5,2])
C0087111 (UMLS CUI [6,1])
C0205265 (UMLS CUI [6,2])
Study Subject Participation Status | Retrospective Study | Protection Study
Item
patients cannot be registered in both the retrospective and protective parts of the study
boolean
C2348568 (UMLS CUI [1])
C0035363 (UMLS CUI [2])
C1545588 (UMLS CUI [3,1])
C0947630 (UMLS CUI [3,2])
Study Subject Participation Status newly present | Participation Retrospective Study Excluded
Item
patients who newly present at the center in the 3 months prior to center activation are still eligible as long as they were not previously included in the retrospective part of the study
boolean
C2348568 (UMLS CUI [1,1])
C0750546 (UMLS CUI [1,2])
C0150312 (UMLS CUI [1,3])
C0679823 (UMLS CUI [2,1])
C0035363 (UMLS CUI [2,2])
C0332196 (UMLS CUI [2,3])
Informed Consent
Item
before patient registration, written informed consent must be obtained according to ich/gcp, and national/local regulations.
boolean
C0021430 (UMLS CUI [1])
Formalin-fixed paraffin-embedded tissue specimen Residual Optional | Tumor tissue sample Frozen Optional | Blood specimen Optional
Item
collection of left-over ffpe and frozen tumor samples as well as blood is optional.
boolean
C2711483 (UMLS CUI [1,1])
C1609982 (UMLS CUI [1,2])
C1518600 (UMLS CUI [1,3])
C0475358 (UMLS CUI [2,1])
C0016701 (UMLS CUI [2,2])
C1518600 (UMLS CUI [2,3])
C0178913 (UMLS CUI [3,1])
C1518600 (UMLS CUI [3,2])
Parts Both
Item
both parts:
boolean
C0449719 (UMLS CUI [1,1])
C1706086 (UMLS CUI [1,2])
Noninfiltrating Intraductal Carcinoma allowed | Condition Invasive cancer Present | Lobular carcinoma in situ of breast allowed
Item
concomitant dcis or lcis are allowed only if invasive cancer is present.
boolean
C0007124 (UMLS CUI [1,1])
C0683607 (UMLS CUI [1,2])
C1705253 (UMLS CUI [2,1])
C0677898 (UMLS CUI [2,2])
C0150312 (UMLS CUI [2,3])
C0279563 (UMLS CUI [3,1])
C0683607 (UMLS CUI [3,2])
Age
Item
patients should be 18 years or over at the time of diagnosis.
boolean
C0001779 (UMLS CUI [1])
Disease stage All Acceptable | Early-Stage Breast Carcinoma | Locally advanced breast cancer | Neoplasm Metastasis | Independent of Treatment | Cancer Other Eligible
Item
the study will accept all stages of disease (e.g. early bc, locally advanced and metastatic disease) independent of the treatment received. patients with past or concurrent other malignancies are eligible.
boolean
C0699749 (UMLS CUI [1,1])
C0444868 (UMLS CUI [1,2])
C1879533 (UMLS CUI [1,3])
C2986665 (UMLS CUI [2])
C3495949 (UMLS CUI [3])
C0027627 (UMLS CUI [4])
C0332291 (UMLS CUI [5,1])
C0087111 (UMLS CUI [5,2])
C1707251 (UMLS CUI [6,1])
C1548635 (UMLS CUI [6,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial